Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Farace, Cristiano ^a   Oliver, Jaime Antonio ^b   Melguizo, Consolacion ^b,c   Alvarez, Pablo ^b,c   Bandiera, Pasquale ^a   Rama, Ana Rosa ^b,c,d   Malaguarnera, Giulia ^e   Ortiz, Raul ^b,c,d   Madeddu, Roberto ^a,f   Prados, Jose ^b,c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Institute of Biopathology and Regenerative Medicine IBIMER   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF JAÉN   (Spain)

^e UNIVERSITY OF CATANIA   (Italy)

^f NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; LUMICAN; MESSENGER RNA; TEMOZOLOMIDE; DACARBAZINE; KERATAN SULFATE; LUM PROTEIN, HUMAN; PROTEOCHONDROITIN SULFATE;

ADAPTATION; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; DECORIN GENE; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUMICAN GENE; NEURAL STEM CELL; NEUROBLASTOMA; PHENOTYPE; STEM CELL NICHE; TUMOR MICROENVIRONMENT; ANALOGS AND DERIVATIVES; BRAIN TUMOR; PATHOLOGY; PHYSIOLOGY;

BRAIN NEOPLASMS; CHONDROITIN SULFATE PROTEOGLYCANS; DACARBAZINE; DECORIN; GLIOBLASTOMA; HUMANS; KERATAN SULFATE; LUMICAN; NEOPLASTIC STEM CELLS; NEUROBLASTOMA; TUMOR MICROENVIRONMENT;

EID: 84941951078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134111     Document Type: Article

References (84)

1. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA: the journal of the American Medical Association. 2013;310(17):1842-50. doi: 10.1001/jama.2013.280319 PMID: 24193082.
2. Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature reviews Cancer. 2013;13(6):397-411. doi: 10.1038/nrc3526 PMID: 23702928.
3. Gutenberg A, Bock HC, Reifenberger G, Bruck W, Giese A. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis. Acta neurochirurgica. 2013;155(3):429-35. doi: 10.1007/s00701-012-1583-y PMID: 23254891.
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine. 2005;352(10):987-96. doi: 10.1056/NEJMoa043330 PMID: 15758009.
5. Oike T, Suzuki Y, Sugawara KI, Shirai K, Noda SE, Tamaki T, et al. Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results. PloS one. 2013;8(11):e78943. doi: 10.1371/journal.pone.0078943 PMID: 24265731.
6. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369(9579):2106-20. doi: 10.1016/S0140-6736 (07) 60983-0 PMID: 17586306.
7. Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP, et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer research. 2010;70(1):46-56. doi: 10.1158/0008-5472. CAN-09-3663 PMID: 20048071.
8. Bonavia R, Inda MM, Cavenee WK, Furnari FB. Heterogeneity maintenance in glioblastoma: a social network. Cancer research. 2011;71(12):4055-60. doi: 10.1158/0008-5472. CAN-11-0153 PMID: 21628493; PubMed Central PMCID: PMC3117065.
9. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396-401. doi: 10.1126/science.1254257 PMID: 24925914.
10. Moore N, Lyle S. Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance. Journal of oncology. 2011;2011. doi: 10.1155/2011/396076
11. Hua Y, Gorshkov K, Yang Y, Wang W, Zhang N, Hughes DP. Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma. Cancer. 2012;118(20):5140-54. doi: 10.1002/cncr.27496 PMID: 22415601; PubMed Central PMCID: PMC3414637.
12. Schatton T, Frank MH. Antitumor immunity and cancer stem cells. Annals of the New York Academy of Sciences. 2009;1176:154-69. doi: 10.1111/j.1749-6632.2009.04568.x PMID: 19796244; PubMed Central PMCID: PMC2893543.
13. Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Molecular cancer. 2011;10:128. doi: 10.1186/1476-4598-10-128 PMID: 21988793; PubMed Central PMCID: PMC3207925.
14. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer cell. 2012;22(6):725-36. doi: 10.1016/j.ccr.2012.09.022 PMID: 23201165; PubMed Central PMCID: PMC3522773.
15. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559-64. doi: 10.1126/science.1203543 PMID: 21436443.
16. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118(3):277-9. doi: 10.1016/j.cell.2004.07.011 PMID: 15294153.
17. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Journal of cellular physiology. 2007;213(2):374-83. doi: 10.1002/jcp. 21223 PMID: 17680632.
18. Brizzi MF, Tarone G, Defilippi P. Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Current opinion in cell biology. 2012;24(5):645-51. doi: 10.1016/j.ceb.2012.07.001 PMID: 22898530.
19. Watt FM, Huck WT. Role of the extracellular matrix in regulating stem cell fate. Nature reviews Molecular cell biology. 2013;14(8):467-73. doi: 10.1038/nrm3620 PMID: 23839578.
20. Sailer MH, Gerber A, Tostado C, Hutter G, Cordier D, Mariani L, et al. Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. Journal of cell science. 2013;126(Pt 16):3533-40. doi: 10.1242/jcs.125757 PMID: 23788430; PubMed Central PMCID: PMC3744023.
21. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 2011;145(6):926-40. doi: 10.1016/j.cell.2011.04.029 PMID: 21663795; PubMed Central PMCID: PMC3930331.
22. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. The Journal of cell biology. 2012;196(4):395-406. doi: 10.1083/jcb.201102147 PMID: 22351925; PubMed Central PMCID: PMC3283993.
23. Morris JPt, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nature reviews Cancer. 2010;10(10):683-95. doi: 10.1038/nrc2899 PMID: 20814421; PubMed Central PMCID: PMC4085546.
24. Chong HC, Tan CK, Huang RL, Tan NS. Matricellular proteins: a sticky affair with cancers. Journal of oncology. 2012;2012:351089. doi: 10.1155/2012/351089 PMID: 22481923; PubMed Central PMCID: PMC3306981.
25. Jogi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Pahlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Experimental cell research. 2004;295(2):469-87. doi: 10.1016/j.yexcr.2004.01.013 PMID: 15093745.
26. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol. 2007;31(2):277-83. PMID: 17611683.
27. Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood. 2004;103(8):2892-9. doi: 10.1182/blood-2003-08-2807 PMID: 15070660.
28. Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. Journal of cellular and molecular medicine. 2011;15(5):1013-31. doi: 10.1111/j.1582-4934.2010. 01236.x PMID: 21155971; PubMed Central PMCID: PMC3633488.
29. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. The FEBS journal. 2010;277(19):3904-23. doi: 10.1111/j.1742-4658.2010.07800.x PMID: 20840587.
30. Edwards IJ. Proteoglycans in prostate cancer. Nature reviews Urology. 2012;9(4):196-206. doi: 10. 1038/nrurol.2012.19 PMID: 22349653.
31. Biglari A, Bataille D, Naumann U, Weller M, Zirger J, Castro MG, et al. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer gene therapy. 2004;11(11):721-32. doi: 10.1038/sj.cgt.7700783 PMID: 15475879; PubMed Central PMCID: PMC2902255.
32. Neill T, Schaefer L, Iozzo RV. Decorin: a guardian from the matrix. The American journal of pathology. 2012;181(2):380-7. doi: 10.1016/j.ajpath.2012.04.029 PMID: 22735579; PubMed Central PMCID: PMC3409438.
33. Sofeu Feugaing DD, Gotte M, Viola M. More than matrix: the multifaceted role of decorin in cancer. European journal of cell biology. 2013;92(1):1-11. doi: 10.1016/j.ejcb.2012.08.004 PMID: 23058688.
34. Engel S, Isenmann S, Stander M, Rieger J, Bahr M, Weller M. Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration. Journal of neuroimmunology. 1999;99(1):13-8. PMID: 10496172.
35. El Behi M, Krumeich S, Lodillinsky C, Kamoun A, Tibaldi L, Sugano G, et al. An essential role for decorin in bladder cancer invasiveness. EMBO molecular medicine. 2013;5(12):1835-51. doi: 10.1002/emmm.201302655 PMID: 24142880; PubMed Central PMCID: PMC3914526.
36. Santra M, Katakowski M, Zhang RL, Zhang ZG, Meng H, Jiang F, et al. Protection of adult mouse progenitor cells and human glioma cells by de novo decorin expression in an oxygen- and glucosedeprived cell culture model system. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2006;26(10):1311-22. doi: 10.1038/sj. jcbfm.9600285 PMID: 16467781.
37. Dil N, Banerjee AG. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head & neck oncology. 2011;3:44. doi: 10.1186/1758-3284-3-44 PMID: 21958730; PubMed Central PMCID: PMC3198745.
38. Dil N, Banerjee AG. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro. Head & neck oncology. 2012;4:11. doi: 10.1186/1758-3284-4-11 PMID: 22507529; PubMed Central PMCID: PMC3370992.
39. Zafiropoulos A, Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN. Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells. Molecular cancer research: MCR. 2008;6(5):785-94. doi: 10.1158/1541-7786. MCR-07-0165 PMID: 18505923.
40. Kasamatsu A, Uzawa K, Minakawa Y, Ishige S, Kasama H, Endo-Sakamoto Y, et al. Decorin in human oral cancer: A promising predictive biomarker of S-1 neoadjuvant chemosensitivity. Biochemical and biophysical research communications. 2015;457(1):71-6. doi: 10.1016/j.bbrc.2014.12.093 PMID: 25550184.
41. Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, et al. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR American journal of neuroradiology. 2012;33(6):1059-64. doi: 10.3174/ajnr. A2917 PMID: 22268080.
42. Yang ZX, Lu CY, Yang YL, Dou KF, Tao KS. Lumican Expression in Pancreatic Ductal Adenocarcinoma. Hepato-gastroenterology. 2012;60(122):349-53. doi: 10.5754/hge12642 PMID: 22951524.
43. Nikitovic D, Chalkiadaki G, Berdiaki A, Aggelidakis J, Katonis P, Karamanos NK, et al. Lumican regulates osteosarcoma cell adhesion by modulating TGFbeta2 activity. The international journal of biochemistry & cell biology. 2011;43(6):928-35. doi: 10.1016/j.biocel.2011.03.008 PMID: 21421073.
44. Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, et al. Identification of cisplatinresistance related genes in head and neck squamous cell carcinoma. International journal of cancer Journal international du cancer. 2010;126(2):437-49. doi: 10.1002/ijc.24704 PMID: 19569180.
45. Zagris N, Gilipathi K, Soulintzi N, Konstantopoulos K. Decorin developmental expression and function in the early avian embryo. The International journal of developmental biology. 2011;55(6):633-9. doi: 10.1387/ijdb.113321nz PMID: 21948712.
46. Kallmann BA, Wagner S, Hummel V, Buttmann M, Bayas A, Tonn JC, et al. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2002;16(6):589-91. PMID: 11919163.
47. Daquinag AC, Zhang Y, Amaya-Manzanares F, Simmons PJ, Kolonin MG. An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell stem cell. 2011;9(1):74-86. doi: 10. 1016/j.stem.2011.05.017 PMID: 21683670.
48. Oe T, Sasayama T, Nagashima T, Muramoto M, Yamazaki T, Morikawa N, et al. Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. Journal of neurochemistry. 2005;94(5):1264-76. doi: 10.1111/j. 1471-4159.2005.03273.x PMID: 15992370.
49. Barkho BZ, Song H, Aimone JB, Smrt RD, Kuwabara T, Nakashima K, et al. Identification of astrocyteexpressed factors that modulate neural stem/progenitor cell differentiation. Stem cells and development. 2006;15(3):407-21. doi: 10.1089/scd.2006.15.407 PMID: 16846377; PubMed Central PMCID: PMC2777811.
50. Scholzen T, Solursh M, Suzuki S, Reiter R, Morgan JL, Buchberg AM, et al. The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. The Journal of biological chemistry. 1994;269(45):28270-81. PMID: 7961765.
51. Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. The FEBS journal. 2010;277(19):3864-75. doi: 10. 1111/j.1742-4658.2010.07797.x PMID: 20840584; PubMed Central PMCID: PMC3000440.
52. Stichel CC, Kappler J, Junghans U, Koops A, Kresse H, Muller HW. Differential expression of the small chondroitin/dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain. Brain research. 1995;704(2):263-74. PMID: 8788923.
53. Chaichana K, Zamora-Berridi G, Camara-Quintana J, Quinones-Hinojosa A. Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies. Stem cells. 2006;24(12):2851-7. doi: 10.1634/stemcells.2006-0399 PMID: 16945995.
54. Galli R. The neurosphere assay applied to neural stem cells and cancer stem cells. Methods in molecular biology. 2013;986:267-77. doi: 10.1007/978-1-62703-311-4-17 PMID: 23436418.
55. Asara Y, Marchal JA, Carrasco E, Boulaiz H, Solinas G, Bandiera P, et al. Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil. International journal of molecular sciences. 2013;14(8):16600-16. doi: 10.3390/ijms140816600 PMID: 23941782; PubMed Central PMCID: PMC3759927.
56. Puglisi MA, Tesori V, Lattanzi W, Gasbarrini GB, Gasbarrini A. Colon cancer stem cells: controversies and perspectives. World journal of gastroenterology: WJG. 2013;19(20):2997-3006. doi: 10.3748/wjg. v19.i20.2997 PMID: 23716979; PubMed Central PMCID: PMC3662939.
57. Gammon L, Biddle A, Heywood HK, Johannessen AC, Mackenzie IC. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PloS one. 2013;8(4):e62493. doi: 10.1371/journal.pone.0062493 PMID: 23638097; PubMed Central PMCID: PMC3640080.
58. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, et al. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia. 2004;6(6):838-45. doi: 10.1593/neo.04310 PMID: 15720811; PubMed Central PMCID: PMC1531688.
59. Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, Sergi Sergi L, et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer research. 2010;70(19):7500-13. doi: 10.1158/0008-5472. CAN-10-2353 PMID: 20858720.
60. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346-54. doi: 10.1038/nature12626 PMID: 24048067.
61. Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, et al. Expression of lumican in human breast carcinoma. Cancer research. 1998;58(7):1348-52. PMID: 9537227.
62. Yamamoto T, Matsuda Y, Kawahara K, Ishiwata T, Naito Z. Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer letters. 2012;320(1):31-9. doi: 10.1016/j. canlet.2012.01.023 PMID: 22266188.
63. Seya T, Tanaka N, Shinji S, Yokoi K, Koizumi M, Teranishi N, et al. Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncology reports. 2006;16(6):1225-30. PMID: 17089042.
64. Naito Z, Ishiwata T, Kurban G, Teduka K, Kawamoto Y, Kawahara K, et al. Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int J Oncol. 2002;20(5):943-8. PMID: 11956587.
65. Matsuda Y, Yamamoto T, Kudo M, Kawahara K, Kawamoto M, Nakajima Y, et al. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int J Oncol. 2008;33(6):1177-85. PMID: 19020750.
66. Feugaing DD, Tammi R, Echtermeyer FG, Stenmark H, Kresse H, Smollich M, et al. Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling. Biochimie. 2007;89(5):637-57. doi: 10.1016/j.biochi.2006.12.012 PMID: 17335953.
67. Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, et al. Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-beta1 regulates cancer cell spreading but not adhesion. Oncoscience. 2014;1(10):634-48. PMID: 25593993; PubMed Central PMCID: PMC4278277.
68. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Developmental biology. 1996;175(1):1-13. doi: 10.1006/dbio.1996.0090 PMID: 8608856.
69. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255(5052):1707-10. PMID: 1553558.
70. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1992;12(11):4565-74. PMID: 1432110.
71. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer cell. 2006;9(5):391-403. doi: 10.1016/j.ccr.2006.03.030 PMID: 16697959.
72. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(25):15178-83. doi: 10.1073/pnas.2036535100 PMID: 14645703; PubMed Central PMCID: PMC299944.
73. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer research. 2004;64(19):7011-21. doi: 10.1158/0008-5472. CAN-04-1364 PMID: 15466194.
74. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401. doi: 10.1038/nature03128 PMID: 15549107.
75. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer research. 2003;63(18):5821-8. PMID: 14522905.
76. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer letters. 2009;279(1):13-21. doi: 10.1016/j. canlet.2009.01.016 PMID: 19232461.
77. Shi MF, Jiao J, Lu WG, Ye F, Ma D, Dong QG, et al. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cellular and molecular life sciences: CMLS. 2010;67(22):3915-25. doi: 10.1007/s00018-010-0420-9 PMID: 20549538.
78. Persano L, Pistollato F, Rampazzo E, Della Puppa A, Abbadi S, Frasson C, et al. BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1alpha stability and MGMT expression. Cell death & disease. 2012;3:e412. doi: 10.1038/cddis.2012.153 PMID: 23076220; PubMed Central PMCID: PMC3481140.
79. Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC, Feng BH, et al. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells. Chinese journal of cancer. 2014;33(2):115-22. doi: 10.5732/cjc.012.10236 PMID: 23958055; PubMed Central PMCID: PMC3935013.
80. Shekhani MT, Jayanthy AS, Maddodi N, Setaluri V. Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies. American journal of stem cells. 2013;2(1):52-61. PMID: 23671816; PubMed Central PMCID: PMC3636725.
81. Mauviel A, Santra M, Chen YQ, Uitto J, Iozzo RV. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. The Journal of biological chemistry. 1995;270(19):11692-700. PMID: 7744809.
82. Bleau AM, Agliano A, Larzabal L, de Aberasturi AL, Calvo A. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment. Histology and histopathology. 2014;29(12):1499-510. PMID: 24887025.
83. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell cycle. 2009;8(20):3274-84. PMID: 19770585; PubMed Central PMCID: PMC2825672.
84. Pietras A, Gisselsson D, Ora I, Noguera R, Beckman S, Navarro S, et al. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. The Journal of pathology. 2008;214(4):482-8. doi: 10.1002/path.2304 PMID: 18189331.